期 |
栏目 |
标题 |
文件 |
卷 7, 编号 3 (2005) |
Articles |
Aromazin: printsip deystviya |
|
卷 9, 编号 3 (2007) |
Articles |
Sutent® (Sutent, SU11248) – novyy mul'titargetnyy ingibitor angiogeneza opukholey |
|
卷 11, 编号 3 (2009) |
Articles |
Gertseptin: mekhanizm deystviya |
|
卷 12, 编号 2 (2010) |
Articles |
Konversiya neoperabel'noy stadiiraka legkogo v operabel'nuyuu EGFR-pozitivnykh patsientovna fone lecheniya gefitinibom:dva klinicheskikh sluchaya |
|
卷 12, 编号 1 (2010) |
Articles |
Primenenie Iressy (gefitiniba)v kachestve terapii pervoy liniidlya lecheniya neoperabel'nykhadenokartsinom legkogo, soderzhashchikhmutatsiyu v gene EGFR |
|
卷 12, 编号 3 (2010) |
Articles |
Spornye aspekty HER2-diagnostiki |
|
卷 16, 编号 2 (2014) |
Articles |
Angiogenesis as a target for cancer therapy |
|
卷 16, 编号 3 (2014) |
Articles |
Modern options in personalized therapy of metastatic cutaneous melanoma |
|
卷 18, 编号 1 (2016) |
Articles |
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia) |
(Rus)
|
卷 18, 编号 4 (2016) |
Articles |
Therapy for patients with non-small cell lung cancer in the Russian Federation: EPICLIN-Lung study |
|
卷 13, 编号 3 (2011) |
Articles |
Rol' gefitiniba v lechenii bol'nykhnemelkokletochnym rakom legkogos mutatsiey v gene retseptoraepidermal'nogo faktora rosta |
|